GlaxoSmithKline PLC, the world’s second largest drugmaker, said Thursday that strong sales propelled double-digit earnings growth in the first quarter as did its British rival AstraZeneca PLC, which raised its earnings outlook for the year.
*For more on this story,
read the full Associated Press article.
